Granules Pharmaceuticals recalls amphetamine capsules due to impurities
Granules Pharmaceuticals is recalling 20mg amphetamine capsules (NDC 70010-032-01) due to failed impurities and degradation specifications. This is a prescription product with a lot number of GPC250179A and expiration date 06-22-2027.
Recall notice
Failed Impurities/Degradation Specifications:
Contact the company
What happened, in plain English
Granules Pharmaceuticals is recalling prescription amphetamine capsules (20mg, 100 capsules) because they failed impurities and degradation specifications. This means the product may contain harmful substances that could cause health risks if taken. Read more at govinfonow.com/recall/31822-granules-pharmaceuticals-recalls-amphetamine-capsules-due-to-impurities.
Source Summary by GovInfoNow · govinfonow.com/recall/31822-granules-pharmaceuticals-recalls-amphetamine-capsules-due-to-impurities · Updated August 17, 2026 · FDA enforcement record: FDA #D-0672-2025
Cite this page
“Granules Pharmaceuticals recalls amphetamine capsules due to impurities.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31822-granules-pharmaceuticals-recalls-amphetamine-capsules-due-to-impurities. Based on FDA recall #D-0672-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0672-2025%22&limit=1).
Why it’s dangerous
The capsules failed impurities and degradation specifications, meaning they may contain harmful substances that could cause health risks when taken. This is a prescription product that requires medical supervision.
Who’s affected
Prescription users of the 20mg amphetamine capsules (NDC 70010-032-01) with lot number GPC250179A are affected. People who have taken these capsules since their manufacture date are at risk.
How to tell if you have this one
Check for the product name 'Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate', 20mg, 100 capsules, NDC 70010-032-01, lot number GPC250179A, and expiration date 06-22-2027.
- Brand
Granules Pharmaceuticals- Category
Drug
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Ongoing- Distribution
Distributed Nationwide in the USA- NDC
70010-029-01, 70010-030-01, 70010-031-01, 70010-032-01, 70010-033-01, 70010-034-01
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0669-2025 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-029-01; Lot#: GPC250158A, Exp Date: 06-22-2027 | 3,384 bottles |
| D-0670-2025 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01; lot#: GPC250159A, Exp Date: 06-22-2027 | 11,895 bottles |
| D-0671-2025 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01; Lot#: GPC250178A, Exp Date: 06-22-2027 | 9,917 bottles |
| D-0672-2025 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01; Lot#: GPC250179A, Exp Date: 06-22-2027 | 11,909 bottles |
| D-0673-2025 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 30 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-034-01; Lot#: GPC250181A, Exp Date: 06-19-2027 | 11,928 bottles |
What to do — step by step
Check Product Details
Look for the NDC code 70010-032-01 and lot number GPC250179A on the product packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 34 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0672-2025 (August 28, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0672-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.